|
chemokine (C-X-C motif) ligand 12 signaling pathway
|
GO_0038146 |
[The series of molecular signals initiated by the binding of the chemokine CXCL12 to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |
|
C-X-C motif chemokine 12 receptor activity
|
GO_0038147 |
[Combining with the C-X-C motif chemokine 12 (CXCL12) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
C-C motif chemokine 2 receptor activity
|
GO_0038149 |
[Combining with the C-C motif chemokine 2 (CCL2) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
C-C chemokine receptor activity
|
GO_0016493 |
[Combining with a C-C chemokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. C-C chemokines do not have an amino acid between the first two cysteines of the characteristic four-cysteine motif.] |
|
ERBB3:ERBB2 complex
|
GO_0038143 |
[A heterodimeric complex between the tyrosine kinase receptor ERBB2 and a ligand-activated receptor ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3.] |
|
ERBB4:ERBB2 complex
|
GO_0038144 |
[A heterodimeric complex between the tyrosine kinase receptor ERBB2 and a ligand-activated receptor ERBB4. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB4.] |
|
macrophage colony-stimulating factor signaling pathway
|
GO_0038145 |
[The series of molecular signals initiated by the binding of the cytokine macrophage colony-stimulating factor (M-CSF) to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |
|
ERBB4-ERBB3 complex
|
GO_0038140 |
[A heterodimeric complex between the tyrosine kinase receptors ERBB4 (also called HER4) and ERBB3 (also called HER3). ERBB3 has impaired kinase activity so relies on the kinase activity of its heterodimer partner for activation and signal transmission.] |
|
ERBB4-ERBB4 complex
|
GO_0038141 |
[A homodimeric complex containing two monomers of the tyrosine kinase receptor ERBB4 (also called HER4).] |
|
EGFR:ERBB2 complex
|
GO_0038142 |
[A heterodimeric complex between the tyrosine kinase receptor ERBB2 and a ligand-activated epidermal growth factor receptor (EGFR/ERBB1). ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as EGFR.] |
|
positive regulation of SREBP signaling pathway in response to decreased oxygen levels
|
GO_0038176 |
[Any process that activates or increases the frequency, rate or extent of the SREBP signaling pathway in response to a decrease in oxygen levels.] |
|
death receptor agonist activity
|
GO_0038177 |
[Interacting with a death receptor such that the proportion of death receptors in an active form is increased. Ligand binding to a death receptor often induces a conformational change to activate the receptor.] |
|
complement component C5a signaling pathway
|
GO_0038178 |
[A G protein-coupled receptor signaling pathway initiated by a C5a component of the complement pathway binding to a complement receptor, and ending with regulation of a downstream cellular process. C5a is a peptide derived from the C5 complement factor.] |
|
complement receptor mediated signaling pathway
|
GO_0002430 |
[The series of molecular signals generated as a consequence of a component of the complement pathway binding to a complement receptor. Such components include both whole complement proteins and fragments of complement proteins generated through the activity of the complement pathway.] |
|
interleukin-33-mediated signaling pathway
|
GO_0038172 |
[The series of molecular signals initiated by interleukin-33 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |
|
interleukin-17A-mediated signaling pathway
|
GO_0038173 |
[The series of molecular signals initiated by interleukin-17A binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |
|
interleukin-17A receptor activity
|
GO_0038174 |
[Combining with the cytokine interleukin-17A and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
interleukin-17 receptor activity
|
GO_0030368 |
[Combining with any member of the interleukin-17 family of cytokines and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
negative regulation of SREBP signaling pathway in response to increased oxygen levels
|
GO_0038175 |
[Any process that stops, prevents or reduces the frequency, rate or extent of the SREBP signaling pathway in response to an increase in oxygen levels.] |
|
nerve growth factor signaling pathway
|
GO_0038180 |
[The series of molecular signals initiated by nerve growth factor (NGF) binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |